Early Pulmonary Rehabilitation Reduces COPD Mortality Risk after Exacerbation


Despite being advised in clinical guidelines, fewer than 2% of COPD patients initiate pulmonary rehabilitation within 90 days of hospitalization.

Peter K. Lindenauer, MD

Peter K. Lindenauer, MD

Early pulmonary rehabilitation initiation following chronic obstructive pulmonary disease (COPD) hospitalization is associated with significantly bettered patient mortality at 1 year, according to new findings among Medicare beneficiaries.

The findings, from a team of Massachusetts-based investigators, evidence current guideline recommendations that pulmonary rehabilitation begin in patients within 3-4 weeks of a COPD exacerbation.

Investigators, led by Peter K. Lindenauer, MD, MSc, of the Institute for Healthcare Delivery and Population Science at the University of Massachusetts Medical School, noted that pulmonary rehabilitation requires patients to adopt both an exercise training commitment as well as education as to how they can improve their own physical and psychological status. It has been previously linked to dyspnea relief, exercise tolerance-improvement, and quality-of-life metric improvement in patients with COPD.

That said, its use among patients with the chronic respiratory disease is limited—despite multiple institutional guidances advocating for it. Lack of a physician referral, access to facilities, or other patient-related barriers are frequently cited reasons for pulmonary rehabilitation being avoided.

At the very least, investigators believe it should still serve a role in the greatest at-risk patients with COPD.

“While pulmonary rehabilitation has traditionally been viewed as beneficial for symptomatic, medically stable patients, recent attention has turned to its role after an exacerbation, when patients are at high risk of experiencing a self-reinforcing spiral of dyspnea-related deconditioning,” they wrote.

As such, Lindenauer and colleagues conducted a retrospective, inception cohort trial with claims data from fee-for-service Medicare beneficiaries who were hospitalized due to COPD in 2014. Their assessment included nearly 200,000 patients from more than 4400 acute care hospitals in the US.

The team sought a primary endpoint of all-cause death within 1 year of discharge from COPD hospitalization. They factored sociodemographic characteristics including age, sex, race/ethnicity, Medicaid dual eligibility, current tobacco use, and distance to nearest pulmonary rehabilitation facility.

Their assessment included 197,376 patients, with a mean age of 76.9 years old, and 58.6% being women.

Of this group, just 2721 (1.5%) initiated pulmonary rehabilitation within 90 days of discharge. A total 38,302 (19.4%) patients died within a year of discharge—but just 7.3% of patients who initiated pulmonary rehabilitation within 90 days. Another 19.6% of patients to initiate rehabilitation after 90 days or not at all died within a year.

Investigators observed a significant drop in one-year mortality risk among patients who initiated pulmonary rehabilitation within 90 days of discharge (absolute risk difference [ARD], -6.7%; 95% CI, -7.9 to -5.6; HR, 0.63; 95% CI, 0.57-0.69; P <.001).

Pulmonary rehabilitation initiation was associated with significantly lower mortality across start dates from 1-30 days (ARD, -4.6%; 95% CI, -5.9 to -3.2; HR, 0.74; 95% CI, 0.67-0.82; P <.001) to 61-90 days after discharge (ARD, -11.1%; 95% CI, -13.2 to -8.4; HR, 0.40; 95 CI, 0.30-0.54; P <.001).

Lindenauer additionally observed a significant association with lower risk of death with every 3 additional rehabilitation sessions (HR, 0.91; 95% CI, 0.85-0.98; P = .01).

Investigators noted that, given the strong association between post-exacerbation pulmonary rehabilitation with lower mortality, it is particularly interest that just ≤2% of all patients had actually initiated treatment with 90 days post-discharge.

“To put this into broader context, noninvasive ventilation and long-term oxygen therapy are the only treatments shown to improve survival for patients requiring hospitalization for COPD,” they wrote. “As such, the results of this study reinforce the importance of developing more effective strategies for increasing participation in rehabilitation.”

That said, they concluded pulmonary rehabilitation’s presence in guideline-advised practices for post-exacerbation care is very evidenced in patients with COPD. The team called for further research into the matter.

The study, “Association Between Initiation of Pulmonary Rehabilitation After Hospitalization for COPD and 1-Year Survival Among Medicare Beneficiaries,” was published online in JAMA.

Recent Videos
A panel of 3 experts on COPD
A panel of 3 experts on COPD
A Promising Pipeline for COPD
Projecting Dupilumab's Fit in COPD
What the Ensifentrine FDA Approval Means for COPD
3 KOLs are featured in this program.
3 KOLs are featured in this program.
Video 10 - "Future Treatment Landscape for COPD"
Video 9 - "Emerging Treatment Approaches in COPD"
Pavel Strnad, MD | Credit: RWTH Aachen
© 2024 MJH Life Sciences

All rights reserved.